[go: up one dir, main page]

PE20001647A1 - Derivados de 3-amino-3-arilpropano-1-ol y procedimiento de preparacion de los mismos - Google Patents

Derivados de 3-amino-3-arilpropano-1-ol y procedimiento de preparacion de los mismos

Info

Publication number
PE20001647A1
PE20001647A1 PE2000000296A PE0002962000A PE20001647A1 PE 20001647 A1 PE20001647 A1 PE 20001647A1 PE 2000000296 A PE2000000296 A PE 2000000296A PE 0002962000 A PE0002962000 A PE 0002962000A PE 20001647 A1 PE20001647 A1 PE 20001647A1
Authority
PE
Peru
Prior art keywords
cyclohexyl
benzyl
phenyl
alkyl
disease
Prior art date
Application number
PE2000000296A
Other languages
English (en)
Inventor
Helmut Buschmann
Bernd Sundermann
Babette-Yvonne Kogel
Hagen-Heinrich Hennies
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20001647A1 publication Critical patent/PE20001647A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/24Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/52Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)

Abstract

SE REFIERE A DERIVADOS DE 3-AMINO-3-ARILPROPAN-1-OL DE FORMULA I, DONDE R1 Y R2 SON ALQUILO C1-C6 O FORMAN JUNTOS UN CICLO (CH2)(2-6) OPCIONALMENTE BENZOCONDENSADO O FENILSUSTITUIDO; R3 ES H, METILO; R4 Y R5 SON ALQUILO C1-C6, CICLOALQUILO C3-C6, FENILO, BENCILO, O JUNTOS FORMAN UN CICLO (CH2)(3-6), CH2CH2OCH2CH2; A ES ARILO OPCIONALMENTE CON HETEROATOMOS EN EL SISTEMA CICLICO; X ES BENCILO O BENZOILO SUSTITUIDO CON R12, R13, R14; R12, R13 Y R14 SON H, F, Cl, Br, CHF2, CF3, OR11, SR11, ENTRE OTROS; R11 ES H, ALQUILO C1-C6, FENILO, BENCILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS DIMETIL-{[2-(2-METILBENCILOXI)CICLOHEXIL]FENIL-METIL}AMINA; 4-TRIFLUORO-METILBENZOATO DE [2-(DIMETILAMINOFENILMETIL)CICLOHEXILO]; 4-METOXI-BENZOATO DE [2-(DIMETILAMINOFENILMETIL)CICLOHEXILO], ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I TIENE AFINIDAD CON EL PUNTO DE LIGADURA 2 DEL CANAL DE SODIO, PUNTO DE LIGADURA DE BENZODIAZEPINA DEL CANAL DE CALCIO DE TIPO L Y PUEDE SER UTIL PARA EL TRATAMIENTO DEL DOLOR NEUROPATICO, CRONICO, ENFERMEDADES CARDIOVASCULARES, INCONTINENCIA URINARIA, DIARREA, PRURITO, DEPENDENCIA DEL ALCOHOL, DEPENDENCIA DE DROGAS, INFLAMACIONES
PE2000000296A 1999-04-07 2000-04-04 Derivados de 3-amino-3-arilpropano-1-ol y procedimiento de preparacion de los mismos PE20001647A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19915602A DE19915602A1 (de) 1999-04-07 1999-04-07 3-Amino-4-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
PE20001647A1 true PE20001647A1 (es) 2001-01-20

Family

ID=7903731

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000296A PE20001647A1 (es) 1999-04-07 2000-04-04 Derivados de 3-amino-3-arilpropano-1-ol y procedimiento de preparacion de los mismos

Country Status (25)

Country Link
US (2) US6288278B1 (es)
EP (1) EP1043306B1 (es)
JP (1) JP2000327643A (es)
KR (1) KR100686475B1 (es)
CN (1) CN1147461C (es)
AR (1) AR023374A1 (es)
AT (1) ATE263138T1 (es)
AU (1) AU777873B2 (es)
BR (1) BR0008681A (es)
CA (1) CA2303721A1 (es)
CO (1) CO5170510A1 (es)
DE (2) DE19915602A1 (es)
DK (1) DK1043306T3 (es)
ES (1) ES2218016T3 (es)
HU (1) HUP0001397A2 (es)
IL (1) IL135452A (es)
NO (1) NO325029B1 (es)
NZ (1) NZ503397A (es)
PE (1) PE20001647A1 (es)
PL (1) PL339487A1 (es)
PT (1) PT1043306E (es)
SI (1) SI1043306T1 (es)
SK (1) SK4952000A3 (es)
UA (1) UA70307C2 (es)
ZA (1) ZA200001747B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19915601A1 (de) * 1999-04-07 2000-10-19 Gruenenthal Gmbh 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
DE10108307A1 (de) * 2001-02-21 2002-08-29 Gruenenthal Gmbh Substituierte Propan-1,3-diamin-Derivate
US6897319B2 (en) * 2001-12-27 2005-05-24 Ortho-Mcneil Pharmaceutical, Inc. Useful aroyl pyrrole heteroaryl methanones and methanols
DE10213051B4 (de) * 2002-03-23 2013-03-07 Grünenthal GmbH Substituierte 4-Aminocyclohexanole
DE102005033732B4 (de) 2005-05-27 2014-02-13 Grünenthal GmbH Trennung stereoisomerer N,N-Dialkylamino-2-alkyl-3-hydroxy-3-phenyl-alkane

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017637A (en) * 1973-03-26 1977-04-12 American Home Products Corporation Benzylamine analgesics
US3937818A (en) * 1974-03-27 1976-02-10 American Home Products Corporation Benzylamine narcotic antagonists
US3975436A (en) * 1974-03-27 1976-08-17 American Home Products Corporation Benzylamine narcotic antagonists
US4143158A (en) * 1978-03-24 1979-03-06 American Home Products Corporation Inhibition of prolactin release by an opiate antagonist
CZ285637B6 (cs) * 1992-10-26 1999-10-13 Gödecke Aktiengesellschaft Tilidindihydrogenortofosfát, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
DE19915601A1 (de) * 1999-04-07 2000-10-19 Gruenenthal Gmbh 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
NO325029B1 (no) 2008-01-21
HK1031722A1 (en) 2001-06-22
AU777873B2 (en) 2004-11-04
DE50005841D1 (de) 2004-05-06
JP2000327643A (ja) 2000-11-28
DE19915602A1 (de) 2000-10-19
KR100686475B1 (ko) 2007-02-23
CN1147461C (zh) 2004-04-28
SK4952000A3 (en) 2000-10-09
AR023374A1 (es) 2002-09-04
DK1043306T3 (da) 2004-07-05
CO5170510A1 (es) 2002-06-27
ES2218016T3 (es) 2004-11-16
CA2303721A1 (en) 2000-10-07
HU0001397D0 (en) 2000-06-28
NZ503397A (en) 2001-04-27
HUP0001397A2 (hu) 2002-04-29
NO20001782L (no) 2000-10-09
KR20000071570A (ko) 2000-11-25
IL135452A0 (en) 2001-05-20
SI1043306T1 (en) 2004-10-31
ZA200001747B (en) 2000-10-26
UA70307C2 (en) 2004-10-15
CN1270163A (zh) 2000-10-18
ATE263138T1 (de) 2004-04-15
BR0008681A (pt) 2002-02-26
EP1043306A3 (de) 2001-07-18
EP1043306A2 (de) 2000-10-11
IL135452A (en) 2004-02-08
PT1043306E (pt) 2004-08-31
USRE39530E1 (en) 2007-03-27
AU2645000A (en) 2000-10-12
US6288278B1 (en) 2001-09-11
EP1043306B1 (de) 2004-03-31
PL339487A1 (en) 2000-10-09
NO20001782D0 (no) 2000-04-06

Similar Documents

Publication Publication Date Title
HU9302328D0 (en) Method for producing 5-heteroyl-indole derivatives and one for preparing pharmaceutical preparatives containing them as active substance
YU48105B (sh) Derivati triazola i postupak za njihovo dobijanje
PE20010402A1 (es) Derivados de 1,5-dihidropirrol-2-ona sustituida
PE20001647A1 (es) Derivados de 3-amino-3-arilpropano-1-ol y procedimiento de preparacion de los mismos
ES510278A0 (es) "un procedimiento para preparar derivados de benzamida".
NO177995C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater
YU47191B (sh) Postupak za dobijanje benzazepin sulfonamida i njegove soli
DK184388A (da) 3h-1,2,3-triazolooe4,5-daapyrimidiner
NO840732L (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse n-(3-trifluormetylfenyl)-n`-propargylpiperazin
PT89000A (pt) Processo para a preparacao de composicoes farmaceuticas e veterinarias analgesicas contendo pirimidinas
ES540511A0 (es) Procedimiento para preparar pirido (1,2-c)imidazo-(1,2-a) bencimidazoles sustituidos
DK115785A (da) Monosilylerede aiminophenylethylamin-derivater, fremgangsmaade til fremstilling deraf og deres anvendelse som vaekstfremmende midler
SE8303564L (sv) N-(4-pyrazolidinyl)benzamider
PE20021007A1 (es) Derivados de 1,3-diaminopropano sustituidos, procedimientos para su preparacion, medicamentos y composiciones farmaceuticas que los contienen
ES532178A0 (es) Procedimiento para preparar nuevas semicarbazidas
DK221786A (da) Phosphorimidater, deres fremstilling og anvendelse til bekaempelse af insekter, mider og nematoder
ES8605277A1 (es) Un procedimiento para obtener nuevos compuestos de cefem
RU2001107026A (ru) N-замещенные производные азабициклогептана, их получение и применение
FI923615L (fi) Substituoituja N3-tioasyylisemikarbatsideja

Legal Events

Date Code Title Description
FC Refusal
FG Grant, registration
FD Application declared void or lapsed